LUNG USO 16156

A Phase IIIb/IV Safety Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with NSCLC

Disease Types

Lung Cancer

Available at

BethesdaClintonColumbiaRockvilleSilver SpringWheaton

Contact

Cheryl Young
(410) 964-2212 ext 1137